Progressive neurocognitive impairment in young adult survivors of childhood acute lymphoblastic leukemia

Pediatric Blood and Cancer

Volumn 53, Issue 2, 2009, Pages 156-161

  Harila, Marika J ^a   Winqvist, Satu ^a   Lanning, Marjatta ^a   Bloigu, Risto ^b   Harila Saari, Arja H ^a  

^a OULU UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF OULU   (Finland)

Author keywords

Acute lymphoblastic leukemia; Childhood cancer survivor; Follow up; Neurocognitive functioning

Indexed keywords

METHOTREXATE; ANTINEOPLASTIC AGENT;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; ATTENTION; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVOR; CHILDHOOD LEUKEMIA; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; DRUG MEGADOSE; FEMALE; HUMAN; INTELLIGENCE QUOTIENT; MAJOR CLINICAL STUDY; MALE; MEMORY; MEMORY DISORDER; MENTAL PERFORMANCE; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; NEUROLOGIC DISEASE; NEUROPSYCHOLOGICAL TEST; ORIENTATION; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; RADIATION DOSE; SKULL IRRADIATION; TREATMENT OUTCOME; BRAIN TUMOR; CHILD; COGNITIVE DEFECT; INFANT; MULTIMODALITY CANCER THERAPY; NEWBORN; ONSET AGE; PRESCHOOL CHILD; SURVIVOR;

ADOLESCENT; ADULT; AGE OF ONSET; ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; COGNITION DISORDERS; COMBINED MODALITY THERAPY; CRANIAL IRRADIATION; DISEASE PROGRESSION; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; NEUROPSYCHOLOGICAL TESTS; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; SURVIVORS; YOUNG ADULT;

EID: 67649971174     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21992     Document Type: Article

References (46)

1. Harras A, Edwards BK, Blot W, et al. editors. Cancer rates and risks, 4th edition. Washington, DC: National Institutes of Health publication no. 96-691, National Cancer Institute; 1996.
2. Gatta G, Capocaccia R, De AR, et al. Cancer survival in European adolescents and young adults. Eur J Cancer 2003;39:2600-2610. (Pubitemid 37468301)
3. Gustafsson G, Schmiegelow K, Forestier E, et al. Improving outcome through two decades in childhood ALL in the Nordic countries: The impact of high-dose methotrexate in the reduction of CNS irradiation. Nordic Society of Pediatric Haematology and Oncology (NOPHO). Leukemia 2000;14:2267-2275. (Pubitemid 32042267)
4. Pui CH, Evans WE. Treatment of acute lymphoblastic leukemia. N Engl J Med 2006;354:166-178.
5. Pui CH, Howard SC. Current management and challenges of malignant disease in the CNS in paediatric leukaemia. Lancet Oncol 2008;9:257-268.
6. Campbell LK, Scaduto M, Sharp W, et al. A meta-analysis of the neurocognitive sequelae of treatment for childhood acute lymphocytic leukemia. Pediatr Blood Cancer 2007;49:65-73. (Pubitemid 46847070)
7. Gaynon PS, Trigg ME, Heerema NA, et al. Children's Cancer Group trials in childhood acute lymphoblastic leukemia: 1983-1995. Leukemia 2000;14:2223-2233.
8. Moore BD III. Neurocognitive outcomes in survivors of childhood cancer. J Pediatr Psychol 2005;30:51-63. (Pubitemid 40041441)
9. Mulhern RK, Palmer SL. Neurocognitive late effects in pediatric cancer. Curr Probl Cancer 2003;27:177-197. (Pubitemid 36876736)
10. Moleski M, Neuropsychological, neuroanatomical, and neurophysiological consequences of CNS chemotherapy for acute lymphoblastic leukemia. Arch Clin Neuropsychol 2000;15:603-630. (Pubitemid 30750703)
11. Schatz J, Kramer JH, Ablin A, et al. Processing speed, working memory, and IQ: A developmental model of cognitive deficits following cranial radiation therapy. Neuropsychology 2000;14:189-200. (Pubitemid 30687598)
12. Winqvist S, Vainionpaa L, Kokkonen J, et al. Cognitive functions of young adults who survived childhood cancer. Appl Neuropsychol 2001;8:224-233. (Pubitemid 34274544)
13. Brown RT, Madan-Swain A, Pais R, et al. Cognitive status of children treated with central nervous system prophylactic chemotherapy for acute lymphocytic leukemia. Arch Clin Neuropsychol 1992;7:481-497.
14. Kato M, Azuma E, Ido M, et al. Ten-year survey of the intellectual deficits in children with acute lymphoblastic leukemia receiving chemoimmunotherapy. Med Pediatr Oncol 1993;21:435-440. (Pubitemid 23202821)
15. Jankovic M, Brouwers P, Valsecchi MG, et al. Association of 1800 cGy cranial irradiation with intellectual function in children with acute lymphoblastic leukaemia. ISPACC. International Study Group on Psychosocial Aspects of Childhood Cancer. Lancet 1994;344:224-227.
16. Cousens P, Waters B, Said J, et al. Cognitive effects of cranial irradiation in leukaemia: A survey and meta-analysis. J Child Psychol Psychiatry 1988;29:839-852. (Pubitemid 18270304)
17. Link K, Moell C, Osterberg K, et al. Adult survivors of childhood acute lymphoblastic leukaemia with GH deficiency have normal self-rated quality of life but impaired neuropsychological performance 20 years after cranial irradiation. Clin Endocrinol (Oxf) 2006;65:617-625. (Pubitemid 44583822)
18. Butler RW, Hill JM, Steinherz PG, et al. Neuropsychologic effects of cranial irradiation, intrathecal methotrexate, and systemic methotrexate in childhood cancer. J Clin Oncol 1994;12:2621-2629.
19. Mulhern RK, Wasserman AL, Fairclough D, et al. Memory function in disease-free survivors of childhood acute lymphocytic leukemia given CNS prophylaxis with or without 1,800 cGy cranial irradiation. J Clin Oncol 1988;6:315-320. (Pubitemid 18065937)
20. Waber DP, Turek J, Catania L, et al. Neuropsychological outcomes from a randomized trial of triple intrathecal chemotherapy compared with 18 Gy cranial radiation as CNS treatment in acute lymphoblastic leukemia: Findings from Dana-Farber Cancer Institute ALL Consortium Protocol 95-01. J Clin Oncol 2007;25:4914-4921. (Pubitemid 350220422)
21. Copeland DR, Moore BD III, Francis DJ, et al. Neuropsychologic effects of chemotherapy on children with cancer: A longitudinal study. J Clin Oncol 1996;14:2826-2835.
22. Waber DP, Carpentieri SC, Klar N, et al. Cognitive sequelae in children treated for acute lymphoblastic leukemia with dexamethasone or prednisone. J Pediatr Hematol Oncol 2000;22:206-213. (Pubitemid 32268304)
23. Butler RW, Copeland DR. Neuropsychological effects of central nervous system prophylactic treatment in childhood leukemia: Methodological considerations. J Pediatr Psychol 1993;18:319-338. (Pubitemid 23197288)
24. Ochs J, Mulhern R, Fairclough D, et al. Comparison of neuropsychologic functioning and clinical indicators of neurotoxicity in long-term survivors of childhood leukemia given cranial radiation or parenteral methotrexate: A prospective study. J Clin Oncol 1991;9:145-151.
25. Wechsler D. Wechsler adult Intelligence Scale manual. New York: Psychological Corporation; 1955.
26. Wechsler D. A standardized memory scale for clinical use. J Psychol 1945;19:87-95.
27. Christensen AL. Luriás neuropsychological investiogation. Copenhagen, Denmark: P.J. Schidts, Boktrykkeri, Vojens; 1975.
28. Vilkki J. Perseveration in memory for figures after frontal lobe lesion. Neuropsychologia 1989;27:1101-1104. (Pubitemid 19226840)
29. Reitan RM. Trail making test results for normal and brain-damaged children. Percept Mot Skills 1971;33:575-581.
30. Stroop JR. Studies of interference in serial verbal reactions. J Exp Psychol 1935;18:643-662.
31. Lezak M. Neuropsychological assessment. New York: Oxford University Press; 1983.
32. Meadows AT, Gordon J, Massari DJ, et al. Declines in IQ scores and cognitive dysfunctions in children with acute lymphocytic leukaemia treated with cranial irradiation. Lancet 1981;2:1015-1018. (Pubitemid 11027578)
33. Copeland DR, Moore BD III, Francis DJ, et al. Neuropsychologic effects of chemotherapy on children with cancer: A longitudinal study. J Clin Oncol 1996;14:2826-2835.
34. Moleski M, Neuropsychological, neuroanatomical, and neurophysiological consequences of CNS chemotherapy for acute lymphoblastic leukemia. Arch Clin Neuropsychol 2000;15:603-630. (Pubitemid 30750703)
35. Peterson CC, Johnson CE, Ramirez LY, et al. A meta-analysis of the neuropsychological sequelae of chemotherapy-only treatment for pediatric acute lymphoblastic leukemia. Pediatr Blood Cancer 2008; (51) 99-104.
36. Mennes M, Stiers P, Vandenbussche E, et al. Attention and information processing in survivors of childhood acute lymphoblastic leukemia treated with chemotherapy only. Pediatr Blood Cancer 2005;44:478-486. (Pubitemid 40614496)
37. Brouwers P, Poplack D. Memory and learning sequelae in longterm survivors of acute lymphoblastic leukemia: Association with attention deficits. Am J Pediatr Hematol Oncol 1990;12:174-181. (Pubitemid 20208592)
38. Rodgers J, Britton PG, Morris RG, et al. Memory after treatment for acute lymphoblastic leukaemia. Arch Dis Child 1992;67:266-268.
39. Mirsky AF, Anthony BJ, Duncan CC, et al. Analysis of the elements of attention: A neuropsychological approach. Neuropsychol Rev 1991;2:109-145.
40. Nathan PC, Patel SK, Dilley K, et al. Guidelines for identification of, advocacy for, and intervention in neurocognitive problems in survivors of childhood cancer: A report from the Children's Oncology Group. Arch Pediatr Adolesc Med 2007;161:798-806. (Pubitemid 47236448)
41. Rodgers J, Marckus R, Kearns P, et al. Attentional ability among survivors of leukaemia treated without cranial irradiation. Arch Dis Child 2003;88:147-150. (Pubitemid 36160645)
42. Langer T, Martus P, Ottensmeier H, et al. CNS late-effects after ALL therapy in childhood. Part III. Neuropsychological performance in long-term survivors of childhood ALL: Impairments of concentration, attention, and memory. Med Pediatr Oncol 2002;38:320-328.
43. Mulhern RK, Butler RW. Neurocognitive sequelae of childhood cancers and their treatment. Pediatr Rehabil 2004;7:1-14. (Pubitemid 38160053)
44. Rodgers J, Horrocks J, Britton PG, et al. Attentional ability among survivors of leukaemia. Arch Dis Child 1999;80:318-323.
45. Cole PD, Kamen BA. Delayed neurotoxicity associated with therapy for children with acute lymphoblastic leukemia. Ment Retard Dev Disabil Res Rev 2006;12:174-183. (Pubitemid 44646326)
46. Reddick WE, Shan ZY, Glass JO, et al. Smaller white-matter volumes are associated with larger deficits in attention and learning among long-term survivors of acute lymphoblastic leukemia. Cancer 2006;106:941-949.